<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "diphenhydrAMINE cap">
<dose><value>25</value>
<value>25 - 50</value>
<value>50</value>
</dose><route><value>PO</value>
</route><form><value>cap</value>
</form><drugname><value>diphenhydrAMINE cap</value>
</drugname><strength><value>25 mg</value>
<value>50 mg</value>
</strength><frequency><value>BID</value>
<value>TID</value>
<value>QID</value>
<value>Q4H</value>
<value>Q6H</value>
<value>ONCE</value>
</frequency><instruction><value>DAY 0. Administer 30 to 60 minutes pre-transplant. May be administered by IV route.</value>
<value>DAY 1 of 21. If oral diphenhydrAMINE has not been taken by patient as instructed, administer 60 minutes pre-PACLitaxel. May be administered by IV route.</value>
<value>DAY 1 of 21. PRN. May be administered by PO route.</value>
<value>DAY 1 of 7. If oral diphenhydrAMINE has not been taken by patient as instructed, administer 60 minutes pre-PACLitaxel. May be administered by IV route.</value>
<value>DAY 1 of 7. PRN. May be administered by IV route.</value>
<value>DAY 1 of 21. PRN. May be administered by IV route.</value>
</instruction><volume></volume><units><value>mg</value>
</units><additionalnotes></additionalnotes><population><value>Adjuvant PACLitaxel/CARBOplatin. Non-Small Cell Lung Cancer</value>
<value>PACLitaxel / CARBOplatin. Advanced / Metastatic Non-Small Cell Lung Cancer</value>
<value>PACLitaxel/CARBOplatin (Weekly) and concurrent RT. Non-Small Cell Lung Cancer.</value>
</population><indicationprn></indicationprn><backgroundinformation></backgroundinformation><prninformation><value>YES</value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>First Generation Antihistamines</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>00757683</value>
<value>00757691</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>